2. Search Result
Search Result
Results for "

5'-CTP trisodium

" in MedChemExpress (MCE) Product Catalog:

10

Inhibitors & Agonists

2

Natural
Products

3

Isotope-Labeled Compounds

3

Oligonucleotides

Cat. No. 상품명 Target 연구분야 Chemical Structure
  • HY-W008915
    Cytidine 5'-diphosphate trisodium salt

    CDP

    		 DNA/RNA Synthesis Metabolic Disease
    Cytidine 5'-diphosphate trisodium salt (CDP) is produced by the transfer of phosphoryl group from ATP to cytidine monophosphate (CMP) catalyzed by uridine monophosphate kinase (UMPK). Cytidine 5′-diphosphate can be used to produce Cytidine triphosphate (CTP) for synthesis of DNA and RNA .
    Cytidine 5'-diphosphate trisodium salt
  • HY-147338A
    5-Methylcytidine 5′-triphosphate trisodium
    1 Publications Verification

    5-Methyl-CTP trisodium

    		 DNA/RNA Synthesis Others
    5-Methylcytidine 5′-triphosphate (5-Methyl-CTP) trisodium is a modified nucleoside triphosphate. 5-Methylcytidine 5′-triphosphate trisodium can apply in replacing unmodified mRNA, resulting in the increase of translational properties and stability, as well as the reduction of innate immune responses in human and other mammalian cells .
    5-Methylcytidine 5′-triphosphate trisodium
  • HY-115740A
    Cytarabine triphosphate trisodium

    Ara-CTP trisodium

    		 DNA/RNA Synthesis Cancer
    Cytarabine triphosphate (Ara-CTP) trisodiu, an active metabolite of Cytarabine, is a competitive inhibitor of DNA synthesis. Intracellular Cytarabine triphosphate trisodiu levels can be used to predict chemosensitivity of leukemic blasts to Cytarabine .
    Cytarabine triphosphate trisodium
  • HY-W008915R
    Cytidine 5'-diphosphate trisodium salt (Standard)

    CDP (Standard)

    		 Reference Standards DNA/RNA Synthesis Metabolic Disease
    Cytidine 5'-diphosphate (trisodium salt) (Standard) is the analytical standard of Cytidine 5'-diphosphate (trisodium salt). This product is intended for research and analytical applications. Cytidine 5'-diphosphate trisodium salt (CDP) is produced by the transfer of phosphoryl group from ATP to cytidine monophosphate (CMP) catalyzed by uridine monophosphate kinase (UMPK). Cytidine 5′-diphosphate can be used to produce Cytidine triphosphate (CTP) for synthesis of DNA and RNA[1][2].
    Cytidine 5'-diphosphate trisodium salt (Standard)
  • HY-171587A
    3′-Deoxy CTP trisodium

    		HCV Infection
    3′-Deoxy CTP trisodium is the sodium salt form of 3′-Deoxy CTP (HY-171587). 3′-Deoxy CTP trisodium is a nucleotide analogue and a mandatory chain terminator. 3′-Deoxy CTP trisodium can cause chain termination by lacking the 3′-hydroxyl group, inhibiting the RNA synthesis activity of HCV nonstructural protein (NS5B) polymerase and blocking viral replication. 3′-Deoxy CTP trisodium can be used to study the chain termination mechanism of HCV polymerase and the development of antiviral drugs .
    3′-Deoxy CTP trisodium
  • HY-147338S
    5-Methylcytidine 5′-triphosphate-d3 trisodium

    5-Methyl-CTP-d3 trisodium

    		 DNA/RNA Synthesis Isotope-Labeled Compounds Others
    5-Methylcytidine 5′-triphosphate-d3 trisodium is the deuterium labeled 5-Methylcytidine 5’-triphosphate trisodium (HY-147338A). 5-Methylcytidine 5′-triphosphate (5-Methyl-CTP) trisodium is a modified nucleoside triphosphate. 5-Methylcytidine 5′-triphosphate trisodium can apply in replacing unmodified mRNA, resulting in the increase of translational properties and stability, as well as the reduction of innate immune responses in human and other mammalian cells .
    5-Methylcytidine 5′-triphosphate-d3 trisodium
  • HY-147338S2
    5-Methylcytidine 5′-triphosphate-d8 trisodium

    5-Methyl-CTP-d8 trisodium

    		 Isotope-Labeled Compounds Inflammation/Immunology
    5-Methylcytidine 5'-triphosphate-d8 trisodium is the deuterium-labeled form of 5-Methylcytidine 5'-triphosphate trisodium (HY-147338A). 5-Methylcytidine 5'-triphosphate (5-Methyl-CTP) trisodium is a modified nucleoside triphosphate. 5-Methylcytidine 5'-triphosphate trisodium can be used to replace unmodified mRNA, resulting in the increase of translational properties and stability, as well as the reduction of innate immune responses in human and other mammalian cells .
    5-Methylcytidine 5′-triphosphate-d8 trisodium
  • HY-147338S1
    5-Methylcytidine 5′-triphosphate-15N2,13C trisodium

    5-Methyl-CTP-15N2,13C trisodium

    		 DNA/RNA Synthesis Others
    5-Methylcytidine 5′-triphosphate- 15N2, 13C (5-Methyl-CTP- 15N2, 13C) trisodium is the 15N and 13C labled 5-Methylcytidine 5′-triphosphate (HY-147338). 5-Methylcytidine 5′-triphosphate is a modified nucleoside triphosphate .
    5-Methylcytidine 5′-triphosphate-15N2,13C trisodium
  • HY-125818D
    Cytidine-5'-triphosphate trisodium

    Cytidine triphosphate trisodium; 5'-CTP trisodium

    		 Nucleoside Antimetabolite/Analog Metabolic Disease
    Cytidine-5'-triphosphate (Cytidine triphosphate) trisodium is a monomeric raw material that can be used for nucleic acid synthesis.
    Cytidine-5'-triphosphate trisodium
  • HY-128788A
    ddhCTP trisodium solution (100 mM)

    		DNA/RNA Synthesis SARS-CoV Endogenous Metabolite Flavivirus Lactate Dehydrogenase Infection
    ddhCTP trisodium solution (100 mM) is an endogenously produced pyrimidine base analog with a Kd of 17.0 nM for LLDH and an IC50 of 55.8 μM for GAPDH. By inhibiting key metabolic enzymes such as GAPDH, ddhCTP trisodium reduces glycolytic flux and shifts metabolic flow toward the pentose phosphate pathway, thereby regulating the redox balance of cells. As a competitive CTP analog, ddhCTP trisodium terminates RNA synthesis by flavivirus RdRps and SARS-CoV-2 RdRp, and inhibits Zika virus replication in vivo. ddhCTP trisodium can be used in studies related to viral infections, COVID-19 and Zika virus infections .
    ddhCTP trisodium solution (100 mM)

온라인 문의

Your information is safe with us. * Required Fields.

호칭

  

Country or Region *

고객명 *

 

회사명 *

Department *

     

메일주소 *

 

상품명 *

Cat. No.

  

Requested quantity *

전화번호 *

     

비고

온라인 문의

Inquiry Information

상품명:
Cat. No.:
수량:
MCE Japan Authorized Agent: